Yes - the US listing was in the SMH today:
US injection
The retractable syringe powerhouse Unilife has come up with a bizarre plan to join News Corporation and shift its domicile from Sydney to the US state of Delaware and list on the Nasdaq.
Even though the much larger US-focused companies Cochlear and CSL are happy to remain listed in Australia, Unilife said yesterday the move was ''designed to make Unilife Australia a more attractive investment for local and international shareholders by creating a structure which the board believes will provide an increased opportunity to broaden the potential scope, liquidity and depth of the company's shareholder base, while maintaining strong ties with Australian investors''.
The company, chaired by the former Sydney bus king Jim Bosnjak, said it plans to cancel the options under its ASX listing and issue replacement options ''under the proposed option scheme of arrangement between Unilife Australia and its option holders''. It failed to say what the scheme of arrangement was.
Last year Unilife managed to ''continue to motivate [the] outstanding ongoing efforts'' of its chief executive, Alan Shortall.
Shareholders passed a resolution that Shortall, on top of his annual options package and $200,000 cash bonus, be given a ''bonus'' 10 million shares or 5 per cent stake in the company, partly as a result of his role in the company's ''initial public offering'' in 2002. The company did not have an IPO as such but was backdoor-listed.
http://business.smh.com.au/business/casino-keen-to-get-its-rock-off-20090901-f6xs.html
Add to My Watchlist
What is My Watchlist?
